Medication Error in the Care of HIV/AIDS Patients: Electronic Surveillance, Confirmation, and Adverse Events

Background:Medication error occurring during the care of HIV-infected patients may lead to treatment failure, drug toxicity, or even death. Objective:The objective of this study was to ascertain and confirm 5 categories of medication error in the care of HIV-infected patients. Research Design:This study was a retrospective study to describe the occurrence of preventable medication error and to determine if adverse events were associated with confirmed errors. A roster of medications for each category of potential errors was created. Computerized pharmacy records were scanned for all dispensing of these medications. Potential errors were confirmed by medical records abstraction. For the incorrect dosing, coadministration of contraindicated medications, and antiretroviral monotherapy error categories, random samples were chart reviewed for confirmation. For the remaining 2 error categories, all potential errors were chart reviewed. The positive predictive value (PPV) of potential errors, the incidence of confirmed error among all new prescription orders filled and the patient characteristics predicting likelihood of error confirmation were estimated for each error category. Subjects:The study sample involved 5473 HIV-infected patients of the Kaiser Permanente Northern California (KPNC) health plan. Results:Among the 5 error categories, PPVs ranged from a high of 80% for coadministration of contraindicated medications to <1% for antiretroviral monotherapy. Incidence of confirmed errors was 9.80 errors per 1000 new prescriptions dispensed for incorrect dosing, 9.51 errors per 1000 for contraindicated medications, and <1.00 for all other categories. Adverse events associated with confirmed errors were observed only in the contraindicated medications error category. The likelihood of a contraindicated medications error was significantly increased among patients ≥50 years of age and decreased among black patients. Conclusions:Use of electronic pharmacy records to ascertain true medication errors appears most reliable when conducting surveillance for contraindicated medications errors and less reliable for other error categories. Lack of confirmation is likely the result of patients’ lack of adherence to drug regimens or providers’ intentional deviation from accepted prescribing guidelines. Only confirmed contraindicated medications errors appear to be linked to adverse events.

[1]  C. Marano,et al.  To err is human. Building a safer health system , 2005 .

[2]  W. Ray,et al.  Prescribing of Contraindicated Protease Inhibitor and Statin Combinations Among HIV-Infected Persons , 2005, Journal of acquired immune deficiency syndromes.

[3]  Jennifer L. Wright,et al.  Efficacy of indinavir–ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures , 2003, AIDS.

[4]  Timothy S Lesar,et al.  Update on prescribing errors with HAART. , 2003, The AIDS reader.

[5]  M. Wilson,et al.  Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital. , 2001, Journal of acquired immune deficiency syndromes.

[6]  L. Kohn The Institute of Medicine report on medical error: overview and implications for pharmacy. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[7]  T S Lesar,et al.  Antiretroviral Prescribing Errors in Hospitalized Patients , 2000, The Annals of pharmacotherapy.

[8]  M A Fischl,et al.  Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel , 2000 .

[9]  Purdy Bd,et al.  Antiretroviral medication errors for patients with HIV infection. , 1999 .

[10]  T. Lesar,et al.  Antiretroviral medication errors for patients with HIV infection. , 1999, The AIDS reader.

[11]  E. Acosta,et al.  Potential confusion with antiretroviral drugs. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[12]  J. T. Johnson,et al.  Two antiretroviral drugs likely to be confused. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  D. Havlir,et al.  New antiretrovirals and new combinations. , 1998, AIDS.

[14]  J. Nowakowski,et al.  “Vira something”: a taste of the wrong medicine , 1997, The Lancet.

[15]  P. Ungvarski,et al.  Errors in prescribing HIV-1 protease inhibitors. , 1997, The Journal of the Association of Nurses in AIDS Care : JANAC.

[16]  J. Kahn,et al.  HIV-1 protease inhibitors. A review for clinicians. , 1997 .

[17]  J. Mellors,et al.  Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor , 1996, Journal of virology.

[18]  J. Condra,et al.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.

[19]  D. Richman,et al.  Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus. , 1994, Journal of acquired immune deficiency syndromes.

[20]  S D Kemp,et al.  Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. , 1991, Science.

[21]  R. Hiatt,et al.  The cost of acquired immunodeficiency syndrome in northern California. The experience of a large prepaid health plan. , 1990, Archives of Internal Medicine.

[22]  B. Bohne,et al.  Location of structurally similar areas in chinchilla cochleas of different lengths. , 1979, The Journal of the Acoustical Society of America.

[23]  R. Woodruff A Simple Method for Approximating the Variance of a Complicated Estimate , 1971 .